BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27600725)

  • 1. Collapsing glomerulopathy in a young woman with APOL1 risk alleles following acute parvovirus B19 infection: a case report investigation.
    Besse W; Mansour S; Jatwani K; Nast CC; Brewster UC
    BMC Nephrol; 2016 Sep; 17(1):125. PubMed ID: 27600725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.
    Moudgil A; Nast CC; Bagga A; Wei L; Nurmamet A; Cohen AH; Jordan SC; Toyoda M
    Kidney Int; 2001 Jun; 59(6):2126-33. PubMed ID: 11380814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Collapsing variant of focal segmental glomerulosclerosis by parvovirus B19: case report].
    Freitas GR; Praxedes MR; Malheiros D; Testagrossa L; Dias CB; Woronik V
    J Bras Nefrol; 2015; 37(1):121-6. PubMed ID: 25923759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis.
    Amoura A; Moktefi A; Halfon M; Karras A; Rafat C; Gibier JB; Gleeson PJ; Servais A; Argy N; Maillé P; Belenfant X; Gueutin V; Delpierre A; Tricot L; El Karoui K; Jourde-Chiche N; Houze S; Sahali D; Audard V
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):964-972. PubMed ID: 32444394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
    Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
    Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor's APOL1 Risk Genotype and "Second Hits" Associated With De Novo Collapsing Glomerulopathy in Deceased Donor Kidney Transplant Recipients: A Report of 5 Cases.
    Chang JH; Husain SA; Santoriello D; Stokes MB; Miles CD; Foster KW; Li Y; Dale LA; Crew RJ; Cohen DJ; Kiryluk K; Gharavi AG; Mohan S
    Am J Kidney Dis; 2019 Jan; 73(1):134-139. PubMed ID: 30054024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19 DNA in kidney tissue of patients with focal segmental glomerulosclerosis.
    Tanawattanacharoen S; Falk RJ; Jennette JC; Kopp JB
    Am J Kidney Dis; 2000 Jun; 35(6):1166-74. PubMed ID: 10845832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
    Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
    Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collapsing glomerulopathy in a 16-year-old girl with pulmonary tuberculosis: the role of systemic inflammatory mediators.
    Coventry S; Shoemaker LR
    Pediatr Dev Pathol; 2004; 7(2):166-70. PubMed ID: 15022071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
    Swaminathan S; Lager DJ; Qian X; Stegall MD; Larson TS; Griffin MD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2607-14. PubMed ID: 16705026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity-related glomerulopathy in the presence of APOL1 risk alleles.
    Valdez Imbert R; Hti Lar Seng NS; Stokes MB; Jim B
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35985743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collapsing glomerulopathy].
    Said JC; Letelier LM; González A; Escobillana C; Pisano R
    Rev Med Chil; 2012 Oct; 140(10):1342-6. PubMed ID: 23559294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsing glomerulopathy.
    Schwimmer JA; Markowitz GS; Valeri A; Appel GB
    Semin Nephrol; 2003 Mar; 23(2):209-18. PubMed ID: 12704581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapsing Focal Segmental Glomerulosclerosis in Viral Infections.
    Muehlig AK; Gies S; Huber TB; Braun F
    Front Immunol; 2021; 12():800074. PubMed ID: 35095882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection.
    Araújo SA; Cordeiro TME; Belisário AR; Araújo RFA; Marinho PES; Kroon EG; de Oliveira DB; Teixeira MM; Simões E Silva AC
    Clin Kidney J; 2019 Jun; 12(3):355-361. PubMed ID: 31198534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19-Associated Glomerular Disease.
    Shetty AA; Tawhari I; Safar-Boueri L; Seif N; Alahmadi A; Gargiulo R; Aggarwal V; Usman I; Kisselev S; Gharavi AG; Kanwar Y; Quaggin SE
    J Am Soc Nephrol; 2021 Jan; 32(1):33-40. PubMed ID: 33214201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal Segmental Glomerulosclerosis.
    Rosenberg AZ; Kopp JB
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):502-517. PubMed ID: 28242845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
    Shirai Y; Miura K; Yabuuchi T; Nagasawa T; Ishizuka K; Takahashi K; Taneda S; Honda K; Yamaguchi Y; Suzuki H; Suzuki Y; Hattori M
    CEN Case Rep; 2020 Nov; 9(4):423-430. PubMed ID: 32621069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
    Zee J; McNulty MT; Hodgin JB; Zhdanova O; Hingorani S; Jefferson JA; Gibson KL; Trachtman H; Fornoni A; Dell KM; Reich HN; Bagnasco S; Greenbaum LA; Lafayette RA; Gipson DS; Brown E; Kretzler M; Appel G; Sambandam KK; Tuttle KR; Chen D; Atkinson MA; Hogan MC; Kaskel FJ; Meyers KE; O'Toole J; Srivastava T; Sethna CB; Hladunewich MA; Lin JJ; Nast CC; Derebail VK; Patel J; Vento S; Holzman LB; Athavale AM; Adler SG; Lemley KV; Lieske JC; Hogan JJ; Gadegbeku CA; Fervenza FC; Wang CS; Matar RB; Singer P; Kopp JB; Barisoni L; Sampson MG
    Pediatr Nephrol; 2021 Sep; 36(9):2747-2757. PubMed ID: 33646395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
    Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
    Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.